A phase II trial of erlotinib monotherapy in advanced pancreatic cancer as a first- or second-line agent

Christos Fountzilas, Ravi Chhatrala, Nikhil Khushalani, Wei Tan, Charles LeVea, Alan Hutson, Chris Tucker, Wen Wee Ma, Graham Warren, Patrick Boland, Renuka Iyer

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Fingerprint Dive into the research topics of 'A phase II trial of erlotinib monotherapy in advanced pancreatic cancer as a first- or second-line agent'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds